Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Retained Earnings (2019 - 2026)

Biodesix filings provide 8 years of Retained Earnings readings, the most recent being -$505.6 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 6.75% to -$505.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$505.6 million, a 6.75% decrease, with the full-year FY2025 number at -$497.8 million, down 7.62% from a year prior.
  • Retained Earnings hit -$505.6 million in Q1 2026 for Biodesix, down from -$497.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$317.6 million in Q1 2022 to a low of -$505.6 million in Q1 2026.
  • Median Retained Earnings over the past 5 years was -$433.2 million (2024), compared with a mean of -$425.3 million.
  • Biggest five-year swings in Retained Earnings: decreased 21.67% in 2022 and later fell 6.75% in 2026.
  • Biodesix's Retained Earnings stood at -$367.4 million in 2022, then decreased by 14.19% to -$419.6 million in 2023, then dropped by 10.23% to -$462.5 million in 2024, then decreased by 7.62% to -$497.8 million in 2025, then fell by 1.57% to -$505.6 million in 2026.
  • The last three reported values for Retained Earnings were -$505.6 million (Q1 2026), -$497.8 million (Q4 2025), and -$493.8 million (Q3 2025) per Business Quant data.